Insider Transactions in Q2 2021 at Alector, Inc. (ALEC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,600
-1.65%
|
$101,200
$22.18 P/Share
|
|
Jun 16
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+1.63%
|
$46,000
$10.14 P/Share
|
|
Jun 15
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.88%
|
$660,000
$22.07 P/Share
|
|
Jun 15
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.81%
|
$270,000
$9.15 P/Share
|
|
Jun 08
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,175
-2.2%
|
$364,325
$19.91 P/Share
|
|
Jun 08
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,175
+3.21%
|
$172,575
$9.15 P/Share
|
|
Jun 02
2021
|
Calvin Yu Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,844
-1.43%
|
$31,348
$17.77 P/Share
|
|
May 21
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,975
-5.19%
|
$269,550
$18.14 P/Share
|
|
May 21
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,975
+2.48%
|
$134,775
$9.15 P/Share
|
|
May 18
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,200
-1.51%
|
$75,600
$18.04 P/Share
|
|
May 18
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+0.75%
|
$37,800
$9.15 P/Share
|
|
May 07
2021
|
Arnon Rosenthal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+9.34%
|
-
|
|
May 07
2021
|
Shehnaaz Suliman President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
May 07
2021
|
Robert King Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+7.93%
|
-
|
|
May 07
2021
|
Robert Paul Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+17.98%
|
-
|
|
May 07
2021
|
Calvin Yu Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+11.21%
|
-
|
|
Apr 07
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,300
-4.73%
|
$423,700
$19.51 P/Share
|
|
Apr 07
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,300
+3.03%
|
$245,300
$11.82 P/Share
|